Acadian Asset Management
NVAX icon

Acadian Asset Management’s Novavax NVAX Stock Holding History

Acadian Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87K Sell
9,293
-14,546
-61% -$130K ﹤0.01% 1781
2026
Q1 		$193K Buy
+23,839
New +$216K ﹤0.01% 1597
2024
Q4 		– Sell
-3,602
Closed -$45K – 2009
2024
Q3 		$45K Buy
+3,602
New +$46.5K ﹤0.01% 1823
2021
Q4 		– Sell
-307
Closed -$63K – 1799
2021
Q3 		$63K Buy
+307
New +$67.7K ﹤0.01% 1524
2015
Q4 		– Sell
-22
Closed -$3K – 1479
2015
Q3 		$3K Buy
+22
New +$4.93K ﹤0.01% 1245

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Acadian Asset Management's NVAX Position: Q2 2026 in Review

Acadian Asset Management reduced its Novavax (NVAX) stake by 61% in Q2 2026, selling an estimated $130K and leaving 9,293 shares worth $87K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Acadian Asset Management first reported a position in NVAX in Q3 2015 and has held it in 5 quarters since. The position peaked at $193K in Q1 2026. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Acadian Asset Management held 9,293 shares of Novavax worth $87K as of Q2 2026.
  • Acadian Asset Management sold 14,546 Novavax shares in Q2 2026, an estimated $130K.
  • Novavax made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1781 holding.
  • Acadian Asset Management first reported a position in Novavax in Q3 2015 and has held it in 5 quarters since.
  • Acadian Asset Management's Novavax position peaked at $193K in Q1 2026.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.